Mettler-Toledo International (MTD) Expected to Announce Earnings on Thursday

Mettler-Toledo International (NYSE:MTD - Get Free Report) will likely be issuing its Q2 2025 quarterly earnings data after the market closes on Thursday, July 31st. Analysts expect the company to announce earnings of $9.57 per share and revenue of $957.41 million for the quarter. Mettler-Toledo International has set its Q2 2025 guidance at 9.450-9.700 EPS and its FY 2025 guidance at 41.250-42.000 EPS.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.90 by $0.29. The business had revenue of $883.74 million during the quarter, compared to analyst estimates of $876.61 million. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The firm's revenue was down 4.6% on a year-over-year basis. During the same period in the previous year, the company earned $8.89 EPS. On average, analysts expect Mettler-Toledo International to post $43 EPS for the current fiscal year and $48 EPS for the next fiscal year.

Mettler-Toledo International Stock Performance

Shares of Mettler-Toledo International stock traded up $3.22 during trading on Friday, hitting $1,263.97. 155,612 shares of the stock traded hands, compared to its average volume of 175,277. The stock has a market cap of $26.27 billion, a P/E ratio of 31.52, a PEG ratio of 3.86 and a beta of 1.37. Mettler-Toledo International has a twelve month low of $946.69 and a twelve month high of $1,546.93. The company has a fifty day moving average price of $1,181.58 and a two-hundred day moving average price of $1,193.94.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction dated Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the transaction, the director owned 120 shares of the company's stock, valued at approximately $139,191.60. This represents a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.94% of the company's stock.

Hedge Funds Weigh In On Mettler-Toledo International

An institutional investor recently raised its position in Mettler-Toledo International stock. Geneos Wealth Management Inc. raised its stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 83.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 66 shares of the medical instruments supplier's stock after buying an additional 30 shares during the quarter. Geneos Wealth Management Inc.'s holdings in Mettler-Toledo International were worth $78,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 95.07% of the company's stock.

Analyst Upgrades and Downgrades

MTD has been the subject of several research reports. Wells Fargo & Company lifted their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a report on Monday, May 5th. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and reduced their price target for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Evercore ISI upped their price target on Mettler-Toledo International from $1,200.00 to $1,280.00 and gave the stock an "outperform" rating in a report on Tuesday, July 8th. Robert W. Baird lowered their price objective on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 22nd. Finally, Citigroup upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and set a $1,400.00 price target on the stock in a research report on Monday, April 7th. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $1,280.90.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.